Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000503512 | SCV000597045 | pathogenic | Phelan-McDermid syndrome | 2015-12-10 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001257626 | SCV001434436 | likely pathogenic | Intellectual disability | 2020-04-20 | criteria provided, single submitter | clinical testing | |
Centogene AG - |
RCV000503512 | SCV002028323 | likely pathogenic | Phelan-McDermid syndrome | 2020-04-20 | criteria provided, single submitter | clinical testing | |
Centre de Biologie Pathologie Génétique, |
RCV002274045 | SCV002559103 | pathogenic | Neurodevelopmental delay | criteria provided, single submitter | clinical testing | ||
Gene |
RCV002466523 | SCV002762147 | pathogenic | not provided | 2022-06-07 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002490842 | SCV002791816 | likely pathogenic | Phelan-McDermid syndrome; Schizophrenia 15 | 2021-09-07 | criteria provided, single submitter | clinical testing |